Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Ezetimibe + statin effective and safe in hypercholesterolemic patients with type 2 diabetes

Sep. 13, 2002

PARS (PARP) activation implicated in autoimmune islet beta-cell destruction in NOD mice

Sep. 13, 2002

Insmed discontinues INS-1 development

Sep. 12, 2002

New cholesterol synthesis inhibitors covered by Mochida patent

Sep. 12, 2002

Structure-activity studies at GSK leading to potent, selective MCH antagonists

Sep. 12, 2002

Pilot study for Ixion's IxOC-2 oral oxalate therapy in hyperoxaluria patients

Sep. 12, 2002

Pramlintide effectively ameliorates excessive glucose fluctuations in diabetics

Sep. 12, 2002

Improved glucose control reported for AC-2993 in type 2 diabetes

Sep. 12, 2002

Inhaled insulin is safe and effective in the management of type 1 and type 2 diabetes

Sep. 12, 2002

Sigma-Tau synthesizes phenylalkylcarboxylates with superior profile to rosiglitazone

Sep. 10, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 24, 2026.
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...